# of patients (THA) | % of patients (THA) | # of patients (Annual Physicals) | % of patients (Annual Physicals) | P-value | ||
---|---|---|---|---|---|---|
Underweight (BMI < 18.5) | 2013 | 5 (n = 832) | 0.6 | 720 (n = 23,837) | 3 | < 0.001 |
2014 | 10 (n = 1,109) | 0.9 | 1,097 (n = 39,341) | 2.8 | < 0.001 | |
2015 | 18 (n = 1,379) | 1.3 | 1,421 (n = 66,708) | 2.1 | 0.035 | |
2016 | 19 (n = 1,584) | 1.2 | 2,085 (n = 99,086) | 2.1 | 0.01 | |
2017 | 18 (n = 1,709) | 1.1 | 3,053 (n = 147,724) | 2.1 | 0.003 | |
2018 | 26 (n = 1,777) | 1.5 | 3,797 (n = 214,520) | 1.8 | 0.328 | |
2019 | 20 (n = 1,547) | 1.3 | 4,281 (n = 236,238) | 1.8 | 0.127 | |
2020 | 13 (n = 1,313) | 1 | 3,965 (n = 212,464) | 1.9 | 0.019 | |
Obese (BMI ≥ 30) | 2013 | 357 (n = 832) | 42.9 | 3,853 (n = 23,837) | 16.2 | < 0.001 |
2014 | 441 (n = 1,109) | 39.8 | 6,957 (n = 39,341) | 17.7 | < 0.001 | |
2015 | 529 (n = 1,379) | 38.4 | 13,945 (n = 66,708) | 20.9 | < 0.001 | |
2016 | 595 (n = 1,584) | 37.6 | 22,605 (n = 99,086) | 22.8 | < 0.001 | |
2017 | 620 (n = 1,709) | 36.3 | 36,671 (n = 147,724) | 24.8 | < 0.001 | |
2018 | 657 (n = 1,777) | 37 | 58,680 (n = 214,520) | 27.4 | < 0.001 | |
2019 | 639 (n = 1,547) | 41.3 | 65,527 (n = 236,238) | 27.7 | < 0.001 | |
2020 | 541 (n = 1,313) | 41.2 | 61,400 (n = 212,464) | 28.9 | < 0.001 | |
Class I Obesity (BMI: 30–34.9) | 2013 | 235 (n = 832) | 28.2 | 2,505 (n = 23,837) | 10.5 | < 0.001 |
2014 | 286 (n = 1,109) | 25.8 | 4,524 (n = 39,341) | 11.5 | < 0.001 | |
2015 | 321 (n = 1,379) | 23.3 | 8,867 (n = 66,708) | 13.3 | < 0.001 | |
2016 | 326 (n = 1,584) | 20.6 | 14,264 (n = 99,086) | 14.4 | < 0.001 | |
2017 | 360 (n = 1,709) | 21.1 | 22,823 (n = 147,724) | 15.4 | < 0.001 | |
2018 | 395 (n = 1,777) | 22.2 | 35,886 (n = 214,520) | 16.7 | < 0.001 | |
2019 | 379 (n = 1,547) | 24.5 | 39,801 (n = 236,238) | 16.8 | < 0.001 | |
2020 | 319 (n = 1,313) | 24.3 | 37,024 (n = 212,464) | 17.4 | < 0.001 | |
Class II Obesity (BMI: 35–39.9) | 2013 | 85 (n = 832) | 10.2 | 851 (n = 23,837) | 3.6 | < 0.001 |
2014 | 97 (n = 1,109) | 8.7 | 1,576 (n = 39,341) | 4 | < 0.001 | |
2015 | 143 (n = 1,379) | 10.4 | 3,303 (n = 66,708) | 5 | < 0.001 | |
2016 | 173 (n = 1,584) | 10.9 | 5,413 (n = 99,086) | 5.5 | < 0.001 | |
2017 | 182 (n = 1,709) | 10.6 | 8,860 (n = 147,724) | 6 | < 0.001 | |
2018 | 164 (n = 1,777) | 9.2 | 14,508 (n = 214,520) | 6.8 | < 0.001 | |
2019 | 168 (n = 1,547) | 10.9 | 16,358 (n = 236,238) | 6.9 | < 0.001 | |
2020 | 145 (n = 1,313) | 11 | 15,412 (n = 212,464) | 7.3 | < 0.001 | |
Class III Obesity (BMI ≥ 40) | 2013 | 37 (n = 832) | 4.4 | 497 (n = 23,837) | 2.1 | < 0.001 |
2014 | 58 (n = 1,109) | 5.2 | 857 (n = 39,341) | 2.2 | < 0.001 | |
2015 | 65 (n = 1,379) | 4.7 | 1,775 (n = 66,708) | 2.7 | < 0.001 | |
2016 | 96 (n = 1,584) | 6.1 | 2,928 (n = 99,086) | 3 | < 0.001 | |
2017 | 78 (n = 1,709) | 4.6 | 4,988 (n = 147,724) | 3.4 | 0.007 | |
2018 | 98 (n = 1,777) | 5.5 | 8,286 (n = 214,520) | 3.9 | < 0.001 | |
2019 | 92 (n = 1,547) | 5.9 | 9,368 (n = 236,238) | 4 | < 0.001 | |
2020 | 77 (n = 1,313) | 5.9 | 8,964 (n = 212,464) | 4.2 | 0.003 |